Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reducing the Abuse Liability of Prescription Opioids in Recreational Drug Users
NCT03837860Phase 1Terminated
- Sponsor
- UT Health San Antonio
- Start
- Apr 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in opioid use disorder (OUD) comparing Oxycodone/Placebo, Oxycodone/Risperidone and Oxycodone/Ziprasidone (3 arms). Primary endpoint: Change in Bipolar Visual Analog Scale (VAS) of Drug Likability at 10 days. Started Apr 2019; status: terminated.
02
Drugs
risperidoneziprasidone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03837860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03837860.